EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study

Carol J Levy iD, Yogish C Kudva, Basak Ozaslan, Kristin Castorino, Grenye O'Malley, Ravinder Jeet Kaur, Camilla M Levister, Mei Mei Church, Donna Desjardins, Shelly McCrady-Spitzer, Selassie Ogyaadu, Mari Charisse Trinidad und 9 weitere

Diabetes Care · 2023

DOI: 10.2337/dc23-0173 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes Care, 2023. Verfasst von Carol J Levy und 20 weiteren Autor:innen. Beteiligte Einrichtung: 1Icahn School of Medicine at Mount Sinai, New York, NY. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE There are no commercially available hybrid closed-loop insulin delivery systems customized to achieve pregnancy-specific glucose targets in the U.S. This study aimed to evaluate the feasibility and performance of at-home use of a zone model predictive controller–based closed-loop insulin delivery system customized for pregnancies complicated by type 1 diabetes (CLC-P). RESEARCH DESIGN AND METHODS Pregnant women with type 1 diabetes using insulin pumps were enrolled in the second or early third trimester. After study sensor wear collecting run-in data on personal pump therapy and 2 days of supervised training, participants used CLC-P targeting 80–110 mg/dL during the day and 80–100 mg/dL overnight running on an unlocked smartphone at home. Meals and activities were unrestricted throughout the trial. The primary outcome was the continuous glucose monitoring percentage of time in the target range 63–140 mg/dL versus run-in. RESULTS Ten participants (HbA1c 5.8 ± 0.6%) used the system from mean gestational age of 23.7 ± 3.5 weeks. Mean percentage time in range increased 14.1 percentage points, equivalent to 3.4 h per day, compared with run-in (run-in 64.5 ± 16.3% versus CLC-P 78.6 ± 9.2%; P = 0.002). During CLC-P use, there was significant decrease in both time over 140 mg/dL (P = 0.033) and the hypoglycemic ranges of less than 63 mg/dL and 54 mg/dL (P = 0.037 for both). Nine participants exceeded consensus goals of above 70% time in range during CLC-P use. CONCLUSIONS The results show that the extended use of CLC-P at home until delivery is feasible. Larger, randomized studies are needed to further evaluate system efficacy and pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HumansFemalePregnancyInfantInsulinBlood GlucoseBlood Glucose Self-MonitoringInsulin Infusion SystemsCross-Over StudiesHypoglycemic AgentsPregnancy OutcomeInsulin, Regular, Human

Substanzen

InsulinBlood GlucoseHypoglycemic AgentsInsulin, Regular, Human

Autor:innen und Institutionen

  • 1Icahn School of Medicine at Mount Sinai, New York, NY.
  • 2Mayo Clinic, Rochester, MN.
  • 3Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA.
  • 4Sansum Diabetes Research Institute, Santa Barbara, CA.
  • 5Mayo Clinic, Scottsdale, AZ.

ORCID-Profile: Carol J Levy, Eyal Dassau

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Leona M. and Harry B. Helmsley Charitable Trust
  • National Institutes of Health

Zitieren

APA

Levy, C. J., Kudva, Y. C., Ozaslan, B., Castorino, K., O'Malley, G., Kaur, R. J., Levister, C. M., Church, M. M., Desjardins, D., McCrady-Spitzer, S., Ogyaadu, S., Trinidad, M. C., Reid, C., Rizvi, S., Deshpande, S., Zaniletti, I., Kremers, W. K., Pinsker, J. E., Doyle, F. J., …, & LOIS-P Diabetes and Pregnancy Consortium (2023). At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study. Diabetes Care. https://doi.org/10.2337/dc23-0173

Vancouver

Levy CJ, Kudva YC, Ozaslan B, Castorino K, O'Malley G, Kaur RJ, et al. At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study. Diabetes Care. 2023. doi:10.2337/dc23-0173

BibTeX
@article{Levy2023,
  author = {Levy, Carol J and Kudva, Yogish C and Ozaslan, Basak and Castorino, Kristin and O'Malley, Grenye and Kaur, Ravinder Jeet and Levister, Camilla M and Church, Mei Mei and Desjardins, Donna and McCrady-Spitzer, Shelly and Ogyaadu, Selassie and Trinidad, Mari Charisse and Reid, Corey and Rizvi, Shafaq and Deshpande, Sunil and Zaniletti, Isabella and Kremers, Walter K and Pinsker, Jordan E and Doyle, Francis J and Dassau, Eyal and LOIS-P Diabetes and Pregnancy Consortium, LOIS-P Diabetes and Pregnancy Consortium},
  title = {At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study},
  journal = {Diabetes Care},
  year = {2023},
  doi = {10.2337/dc23-0173}
}
Kostenlos starten →